drugset / Trial / NCT01113580
A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the 2010/2011 Formulation Enzira vaccine is safe and elicits an immune response to seasonal influenza in healthy adults.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enzira® Vaccine | Vaccine | 45 ug | Intramuscular |